Prevalence and risk factors of diabetic nephropathy in Omani type 2 diabetics in Al-Dakhiliyah region

Oman Medical Journal

Volumn 27, Issue 3, 2012, Pages 212-216

  Alrawahi, Abdulhakeem Hamood ^a   Rizvi, Syed Gauhar A ^b   Al Riami, Dawood ^c   Al Anqoodi, Zaher ^a  

^a Directorate General of Health Services   (Oman)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Albuminuria; Diabetic nephropathy; Omani; Prevalence; Risk factors; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CALORIMETER; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUESTIONNAIRE; RISK FACTOR;

EID: 84864477090     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2012.48     Document Type: Article

References (44)

1. Evans TC, Capell P. Diabetic nephropathy. Clin Diabetes 2000;18(1). http://journal.diabetes.org/clinicaldiabetes/v18n12000/Pg7.htm. Accessed 22 May 2011.
2. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999 Oct;341(15):1127-1133.
3. U.S. Renal Data System. USRDS 2005 Annual Data Report: Atlas of End- Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005.
4. American Diabetic Association. Nephropathy in diabetes.Diabetic care. Available at: http://care.diabetesjournals.org/content/26/6/1781.full. Accessed on May 21, 2011.
5. Stengel B, Billon S, Van Dijk PC, Jager KJ, Dekker FW, Simpson K, et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003 Sep;18(9):1824-1833.
6. Vecihi Batuman. Diabetic nephropathy. Available at: http://emedicine.medscape.com/article/238946-clinical#a0256. Accessed on May 22, 2011.
7. Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, et al. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Research and Clinical Practice. 2007 Feb; 75(2):184-192.
8. Directorate general of planning/Ministry of Health, Oman. Annual Health Report 2009 A.D. 2010: chapter 1, page 4.
9. The World Health Organization. global info base. Available at: https://apps.who.int/infobase/Indicators.aspx. Accessed on 23 May 2011.
10. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med 2002 Nov;19(11):954-957.
11. Al-Futaisi A, Al-Zakwani I, Almahrezi A, Al-Hajri R, Al-Hashmi L, Al- Muniri A, et al. Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: a cross-sectional observational study in Oman. Diabetes Res Clin Pract 2006 May;72(2):212-215.
12. Oman renal data system, renal dialysis center, DGHS, Muscat, MOH.
13. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006 Jun;69(11):2057-2063.
14. Prashant P, Sulaiman KJ, Kadaha G, Bazarjani N, Bakir S, El Jabri K, et al. Prevalence and risk factors for albuminuria among type 2 diabetes mellitus patients: A Middle-East perspective. Diabetic Research and clinical practice. 2010:doi:10.1016/j.diabres.2010.02.004.
15. Modebe O, Masoomi MA. Microalbuminuria and associated factors in Bahraini patients with type 2 diabetes mellitus. Ann Saudi Med 2000 Mar;20(2):157-160.
16. Huraib S, Abu-Aisha H, Sulimani RA, Famuyiwa FO, Al-Wakeel J, Askar A, et al. The pattern of diabetic nephropathy among Saudi patients with noninsulin-dependent diabetes mellitus. Ann Saudi Med 1995 Mar;15(2):120-124.
17. Afkhami-Ardekani M, Modarresi M, Amirchaghmaghi M. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian. J Nephrol 2008;18(3):112-117.
18. IranparvarAlamdari M. Aminisani N, Bashardoost B, Shamshirgaran SM, Khodamo-radzadeh M, Shokrabadi M, Olomi B. prevalence and Risk Factors of Microalbuminuria in Type 2 Diabetic Patients in a Diabetic Clinic of Ardabil-Iran. Int J Endocrinol Metab 2006;4:8-12.
19. Ahmedani MY, Hydrie MZ, Iqbal A, Gul A, Mirza WB, Basit A. Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan: a multicenter study. J Pak Med Assoc 2005 Sep;55(9):382-386.
20. Vijay V, Snehalatha C, Ramachandran A, Viswanathan M. Prevalence of proteinuria in non-insulin dependent diabetes. J Assoc Physicians India 1994 Oct;42(10):792-794.
21. Shekiba M, Afkhami-Ardekani M, Orafa AM. The prevalence of micro and macroalbuminuria in diabetic patients referring to diabetes research center. J ShahidSadoughiUniv Med Sci Health Services 2003;10:20-24.
22. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J 2001 Jun;77(908):399-402.
23. Ko GT, Chan JC, Lau M, Cockram CS. Diabetic microangiopathic complications in young Chinese diabetic patients: a clinic-based crosssectional study. J Diabetes Complications 1999 Sep-Dec;13(5-6):300-306.
24. Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005 Jan;48(1):17-26.
25. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003 Jan;63(1):225-232.
26. Gall MA, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991 Sep;34(9):655-661.
27. Gall M-A, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997 Mar;314(7083):783-788.
28. Allawi J, Rao PV, Gilbert R, Scott G, Jarrett RJ, Keen H, et al. Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) 1988 Feb;296(6620):462-464.
29. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, et al; American Diabetic Association. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007 Aug;30(8):2019-2024.
30. Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 1998 Aug;15(8):672-677.
31. Sigdel M, Rajbhandari N, Basnet S, Nagila A, Basnet P, Tamrakar BK; M Sigdel M. Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal. Nepal Med Coll J 2008 Dec;10(4):242-245.
32. Gohar Rehman. Sumera Afzal Khan, Muhammad Hamayun.Studies on diabetic nephropathy and secondary diseases in type 2 diabetes. INT. J. DIAB. DEV. Countries. 2005;25:25-29.
33. Joost BW, van der Meer, John P. Mackenbach. The care and course of diabetes: differences according to level of education. Health Policy. 1999 Jan; 46(2): 127-141.
34. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006 Jun;55(6):1832-1839.
35. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998 May;158(9):998-1004.
36. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002 Mar;61(3):1086-1097.
37. Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 1994 Mar;43(3):441-446.
38. Lövestam-Adrian M, Agardh E, Agardh CD. The incidence of nephropathy in type 1 diabetic patients with proliferative retinopathy: a 10-year follow-up study. Diabetes Res Clin Pract 1998 Jan;39(1):11-17.
39. Adler S. Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004 Nov;66(5):2095-2106.
40. Krolewski AS, Fogarty DG, Warram JH. Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? Diabetes Res Clin Pract 1998 Apr;39(Suppl):S1-S14.
41. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998 Jul;352(9123):213-219.
42. Trevisan R, Viberti G. Genetic factors in the development of diabetic nephropathy. J Lab Clin Med 1995 Oct;126(4):342-349.
43. Satko SG, Langefeld CD, Daeihagh P, Bowden DW, Rich SS, Freedman BI. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002 Sep;40(3):489-494.
44. Kanakamani J, Ammini AC, Gupta N, Dwivedi SN. Prevalence of microalbuminuria among patients with type 2 diabetes mellitus-a hospitalbased study from north India. Diabetes Technol Ther 2010 Feb;12(2):161-166.